Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| 17-alpha-Estradiol | Arimistane | |
|---|---|---|
| Category | Hormones | Hormones |
| Standard Dose | — | — |
| Timing | — | — |
| Cycle Duration | — | — |
| Evidence Level | Preclinical | Low |
Non-feminizing estrogen that extends lifespan in male mice via metabolic improvements. Reduces hepatic mTOR signaling, improves glucose homeostasis, and reduces inflammation without estrogenic effects on reproductive tissues.
Suicidal aromatase-modulating compound marketed to reduce estrogen conversion, though evidence quality and product purity vary.
Fast buy links (we may earn a small commission at no extra cost).
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →